News

                        Array
(
    [0] => stdClass Object
        (
            [id] => 1275
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => gentis-11.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 1
            [displayed_time] => 2025-01-14
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2025-01-14 10:08:21
            [updated_time] => 2025-01-14 10:16:28
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Breakthroughs-in-the-application-of-genetic-testing-in-reproductive-medicine-worldwide-and-in-Vietnam
            [title] => Breakthroughs in the Application of Genetic Testing in Reproductive Medicine Worldwide and in Vietnam
            [description] => During her visit and work in Vietnam, Assoc. Prof. Dr. Francesca Spinella (Senior Medical Information Specialist at Eurofins Genoma Group, Former President of ESHRE PGT Consortium) expressed her admiration for the remarkable advancements made by genetic testing laboratories in the diagnosis and treatment within the field of reproductive medicine. In particular, she praised GENTIS for both its professional expertise and state-of-the-art facilities. She mentioned that the collaboration between GENTIS and GENOMA will enhance multi-level development among global healthcare organizations, particularly in the area of genetic testing.
            [content] => 
Genetic Breakthroughs in Preimplantation Genetic Testing Being Applied in Europe and Vietnam
Assoc. Prof. Dr. Francesca Spinella explained that there are currently three widely used preimplantation genetic testing techniques being applied across Europe and globally: PGT-A, PGT-SR, and PGT-M. These primary methods help improve the success rates of in vitro fertilization (IVF) while reducing the risk of serious genetic disorders in future generations.
Among these, PGT-A helps detect chromosomal aneuploidy to screen out embryos that have abnormalities. This method has been proven to increase IVF success rates, decrease miscarriage rates, and ensure that the embryos implanted are the healthiest.
PGT-M is used to detect genetic mutations that could be inherited from parents, helping to avoid passing on common monogenic disorders like thalassemia, cystic fibrosis, Huntington's disease, and other genetic conditions. PGT-SR can detect structural chromosome abnormalities such as translocations, inversions, or deletions. These abnormalities can cause pregnancy complications and increase the risk of giving birth to a child with birth defects.
In addition to the widely implemented techniques, Assoc. Prof. Dr. Francesca Spinella mentioned two promising new methods that are being researched and developed in Europe: Non-invasive PGT-A (NiPGT-A) and PGT for ploidy (Ploidy). These breakthroughs are driven by the rapid development of genetic sequencing technologies, opening new possibilities for reproductive healthcare.
NiPGT-A represents a breakthrough in preimplantation genetic testing, allowing for testing without the need for embryo biopsy, thus minimizing potential risks to the embryo. This method detects chromosomal abnormalities in embryos from the culture medium, providing greater convenience and safety. Meanwhile, PGT for ploidy (Ploidy) is an advanced test that accurately determines the number of chromosomes in the embryo, helping to select embryos with a complete chromosomal set, thereby reducing the risk of reproductive issues or birth defects.
Assoc Prof. Dr. Francesca Spinella also expressed her deep impression with the preimplantation genetic testing methods being used in Vietnam. She stated that the expertise and modern facilities of the labs, especially at GENTIS, are on par with leading genetic testing centers worldwide.
Assoc Prof. Dr. Francesca Spinella Visits and Works at GENTIS Lab
In addition to common tests like PGT-A, PGT-M, and PGT-SR, GENTIS is also focusing on researching and developing two breakthrough techniques: PGT-Next and PGT-Upgrade. PGT-Next is an advanced method that combines the features of both PGT-A and PGT-SR, with the added capability of detecting chromosomal number abnormalities such as polyploidy and haploidy in embryos. This improves diagnostic accuracy, minimizes the risk of pregnancy with embryos that have chromosomal abnormalities, and optimizes the chances of a healthy pregnancy.
PGT-Upgrade is a significant advancement in genetic diagnosis of embryos. In addition to detecting abnormalities in chromosome number (PGT-A) and structure (PGT-SR), PGT-Upgrade can identify balanced chromosomal translocations passed from parents to embryos. This method helps detect hidden risks that PGT-A and PGT-SR cannot diagnose, while also identifying genetic factors that could affect the health of future generations. PGT-Upgrade offers superior advantages in selecting healthy embryos for artificial reproduction, thereby improving IVF success rates.
Strengthening Relationships and Promoting Multilateral Cooperation Among Global Healthcare Organizations
Promising Collaboration Between GENTIS and GENOMA
Through her visit and discussions, Assoc. Prof. Dr. Francesca Spinella noted that Vietnam’s healthcare services, particularly in reproductive medicine, have significant potential for growth. She emphasized that this event not only provided an opportunity to exchange ideas on advancements in genetic testing but also served as a clear testament to the sustainable and strategic partnership between GENTIS and GENOMA, both members of the Eurofins family. The cooperation between GENTIS and GENOMA is not based solely on commercial interests but also on the shared commitment to scientific research and advanced technologies. Both organizations share values in improving reproductive health and providing accurate and reliable genetic testing services for families and healthcare professionals in their reproductive health journeys.
This collaboration also allows GENTIS to access the latest genetic testing technologies and implement them in Vietnam, enhancing the quality of reproductive healthcare services domestically and contributing to the development of the genetic testing industry in Southeast Asia. GENTIS’s clients will now benefit from advanced genetic testing services, which offer the opportunity for healthy childbirth and minimize risks during pregnancy.

            [content_more] => 
            [meta_title] => Breakthroughs in the Application of Genetic Testing in Reproductive Medicine Worldwide and in Vietna
            [meta_description] => During her visit and work in Vietnam, Assoc. Prof. Dr. Francesca Spinella, she mentioned that the collaboration between GENTIS and GENOMA will enhance multi-level development among global healthcare organizations, particularly in the area of genetic testi
            [meta_keyword] => GENTIS,pgt
            [thumbnail_alt] => 
            [post_id] => 1275
            [category_id] => 4
        )

    [1] => stdClass Object
        (
            [id] => 1274
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => gentis-6.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 1
            [displayed_time] => 0000-00-00
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2025-01-11 08:29:18
            [updated_time] => 2025-01-13 15:57:55
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => learning-about-new-genetic-tests-in-reproductive-support-worldwide-and-their-application-in-europe-with-assoc-prof-dr-francesca-spinella
            [title] => Learning About New Genetic Tests in Reproductive Support Worldwide and Their Practical Application in Europe with Assoc. Prof. Dr. Francesca Spinella
            [description] => With the goal of updating knowledge to enhance the effectiveness of medical examination and treatment, as well as to introduce reproductive support techniques being applied in Europe, the GENTIS Genetic Counseling Center successfully organized the 5th edition of the Genetic Counseling Talkshow - Discussion with Experts. The theme was “Application of New Genetic and Genomic Testing in Reproductive Support Worldwide and Their Practical Use in Europe.” GENTIS was honored to have Assoc. Prof. Dr. Francesca Spinella (Senior Medical Information Specialist of Eurofins Genoma Group, Former Chair of the ESHRE PGT Consortium) and Dr. ThS. BSNT Đinh Thị Quỳnh Ngọc (GENTIS Genetic Counseling Center) as speakers. The program attracted widespread attention from doctors, specialists, and many audiences interested in reproductive support methods.
            [content] => 
Speaking about the pre-implantation genetic testing (PGT) techniques currently used in Europe, Assoc. Prof. Dr. Francesca Spinella said: "Currently, there are three common types of pre-implantation genetic tests: PGT-A, PGT-SR, and PGT-M. PGT-A is used to detect chromosomal abnormalities, allowing the selection of embryos without chromosomal abnormalities for embryo transfer. PGT-M is a tool to detect genetic mutations that could be inherited from the parents, thereby preventing the transfer of embryos with genetic disorders. PGT-SR is a method capable of detecting structural chromosomal abnormalities of 5Mb or more in embryos, thus increasing the chances of achieving a successful pregnancy by selecting normal embryos."
In addition to the three conventional PGT tests, Assoc. Prof. Dr. Francesca Spinella also discussed two new methods: Non-invasive PGT-A (NiPGT-A) and PGT for Ploidy (Ploidy). “NiPGT-A provides the opportunity to test embryos without the need for biopsy, by analyzing DNA in the culture medium. Meanwhile, PGT for Ploidy helps detect the presence of specific chromosomal abnormalities in embryos, thus avoiding the transfer of these embryos." However, she also mentioned that more research is needed to further validate the effectiveness of these two methods.

Assoc. Prof. Dr. Francesca Spinella also addressed several audience questions, including the importance of genetic counseling in IVF procedures, criteria for selecting mosaic embryos for transfer, and especially the appropriate timing for performing PGT methods, especially PGT for Ploidy. She spent a lot of time discussing the advantages, practical applications, and outcomes that can be achieved by using the genetic testing methods currently applied in Europe.
Understanding the concerns of infertile couples about the cost of these procedures, Assoc. Prof. Dr. Francesca Spinella shared: "The new PGT tests are optimal methods, incorporating advanced techniques from pre-implantation genetic screening. Therefore, it is understandable that the costs of these tests are slightly higher. However, in the future, the cost of these tests may decrease due to rapid technological advancements and the widespread adoption of testing. For example, the first PGT tests had extremely high costs when they were first introduced, but over time, the costs have stabilized, allowing many patients to access this method."
Notably, during the conversation, Assoc. Prof. Dr. Francesca Spinella provided in-depth insights and timely answers, helping doctors, specialists, and viewers better understand the application of current pre-implantation genetic tests. The Talkshow program was a success, attracting thousands of views, numerous shares, and receiving a lot of support from the audience.

Before concluding the Talkshow, Assoc. Prof. Dr. Francesca Spinella shared that she was very impressed after visiting some PGT and IVF labs in Vietnam, particularly GENTIS. She further mentioned that she was impressed with the facilities and the quality of healthcare professionals in Vietnam. Additionally, Assoc. Prof. Dr. Francesca Spinella noted that “Vietnam’s healthcare services in general, and reproductive support in particular, have a lot of potential for development” and emphasized the collaborative relationship within the Eurofins family, both scientifically and commercially.
We hope that the insights shared by the experts during the Talkshow will be beneficial for doctors and the audience. GENTIS Genetic Counseling Center sincerely thanks the doctors, partners, experts, and clients for their participation. We will continue to organize more Genetic Counseling Talkshow programs to provide valuable information to the audience.



            [content_more] => 
            [meta_title] => Learning About New Genetic Tests in Reproductive Support Worldwide and Their Practical Application i
            [meta_description] => With the goal of updating knowledge to enhance the effectiveness of medical examination and treatment, as well as to introduce reproductive support techniques being applied in Europe, the GENTIS Genetic Counseling Center successfully organized the 5th edi
            [meta_keyword] => Gentis,PGT
            [thumbnail_alt] => 
            [post_id] => 1274
            [category_id] => 4
        )

    [2] => stdClass Object
        (
            [id] => 1273
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => 461103487_919832673515258_4243371323831293845_n.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 1
            [displayed_time] => 2024-12-22
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2025-01-08 13:49:54
            [updated_time] => 2025-01-09 09:18:38
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Gentis-accompanies-the-Androilogy-and-fertility-hospital-of-hanoi-at-the-5th-Scientific-Conference
            [title] => Gentis accompanies the Andrology and fertility hospital of Hanoiat the 5th Scientific
            [description] => On the morning of September 22, 2024, Hanoi Hospital for Male Health and Infertility (AF HANOI) successfully organized the "5th Scientific Conference." This event is part of a series of activities celebrating the 15th anniversary of the hospital's establishment. The conference provided an opportunity for experts and doctors to discuss the current state of male infertility treatment from practical and diverse perspectives. Additionally, several new research findings were shared by leading specialists and experienced doctors to update effective treatment methods for patients. GENTIS is honored to accompany the Hanoi Hospital for Male Health and Infertility as a sponsor, contributing to the success of the conference.
            [content] => 
The event was attended by esteemed guests, including Prof. Dr. Nguyen Dinh Tao, President of the Hanoi Fertility Support Association; former Deputy Director of the Embryo Technology Center (now the Army Clinical Morphology Institute – Military Medical Academy); Prof. Tran Thi Phuong Mai, former Deputy Head of the Maternal and Child Health Department; Assoc. Prof. Dr. Nguyen Quang, President of the Vietnam Sexual Medicine Association, Director of the Male Health Center, Viet Duc Friendship Hospital, along with nearly 200 delegates who are leading experts and doctors from major hospitals and medical centers across the country. From the Hanoi Hospital for Male Health and Infertility, attendees included: Assoc. Prof. Dr. Le Thi Thu Hien – Medical Director of the Hospital; Dr. CKI Pham Van Huong – Deputy Medical Director, Head of the Assisted Reproductive Technology Department; Assoc. Prof. Nguyen Minh Duc, Head of the Assisted Reproductive Technology Laboratory; and Dr. Dinh Huu Viet - Head of the Male Health Department.

At the 5th Scientific Conference, alongside research presentations from leading experts from major hospitals and fertility centers, such as the report "Male Infertility: Current Challenges and Future Directions" by Assoc. Prof. Dr. Nguyen Quang, and "Disorders of Sexual Development and Reproductive Function" by Assoc. Prof. Dr. Vu Chi Dung, the Hanoi Hospital for Male Health and Infertility contributed three reports on highly practical topics: “Male Infertility from a Practical Perspective at the Hanoi Hospital for Male Health and Infertility” by Dr. Dinh Huu Viet; “Preparation of Severe Abnormal Sperm Samples in Assisted Reproduction” by Assoc. Prof. Nguyen Minh Duc; and “Genetic Testing Before Embryo Transfer in Male Infertility: When is it Necessary?” presented by Dr. Bui Thi Phuong Hoa, a genetics specialist. These three topics were synthesized and researched by doctors and embryologists to share knowledge and gather feedback from leading experts in genetics, male health, and reproductive support. The aim was also to provide new perspectives on male infertility treatment from genetic and embryological aspects in actual clinical practice.
Speaking at the conference, Assoc. Prof. Dr. Le Thi Thu Hien (Medical Director of the Hospital) stated, “In addition to our daily medical examination and treatment activities, the Hanoi Hospital for Male Health and Infertility is particularly focused on scientific research. Scientific research helps create reliable new knowledge, enhances treatment quality and safety for patients, and increases effectiveness at reasonable costs. Moreover, scientific research enables doctors and healthcare staff to continuously improve their knowledge and skills while addressing issues in their professional work, aiming to deliver the best outcomes for patients. We have been and are striving to excel in both medical treatment and scientific research to bring new breakthroughs to our nation's healthcare."

The conference successfully created an open forum for sharing experiences and knowledge. The enthusiastic participation of experts and doctors fostered a vibrant and beneficial discussion space, aiming to find new directions for the field of male health. The hospital expresses sincere gratitude to all speakers and esteemed delegates, experts, and doctors who contributed to the success of this conference.
            [content_more] => 
            [meta_title] => Gentis accompanies the Andrology and fertility hospital of Hanoi at the 5th Scientific Conference
            [meta_description] => On the morning of September 22, 2024, Hanoi Hospital for Male Health and Infertility (AF HANOI) successfully organized the "5th Scientific Conference.".  GENTIS is honored to accompany the Hanoi Hospital for Male Health and Infertility as a sponsor, contr
            [meta_keyword] => Gentis
            [thumbnail_alt] => 
            [post_id] => 1273
            [category_id] => 4
        )

    [3] => stdClass Object
        (
            [id] => 1272
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => Ảnh.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 1
            [displayed_time] => 2024-12-09
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2025-01-08 13:39:57
            [updated_time] => 2025-01-09 09:21:30
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Gentis-accompanies-the-journey-of-spearding-love-at-the-Gala-Seeds of Aspiration
            [title] => GENTIS Accompanies the Journey of Spreading Love at the Gala "Seeds of Aspiration"
            [description] => On the evening of December 7, 2024, the second Gala "Seeds of Aspiration" was successfully held at the Military Broadcasting and Television Center. During the event, the organizers announced and awarded the decision to support 100% of the costs for In Vitro Fertilization (IVF) under the program "Support for Infertile Soldiers - Love Spreads" for 2024 to 10 families of infertile soldiers.
            [content] => 

Immediately after the "Support for Infertile Soldiers - Love Spreads" program was widely announced in the media, many applications from military families were submitted. The expert council from the hospital and the Military Broadcasting and Television Center worked impartially, carefully reviewing each case to grant 10 families free IVF support for 2024.
The 10 selected cases for free IVF will receive 100% coverage of costs, including expenses for testing, egg stimulation, egg retrieval, embryo creation, embryo storage, and embryo transfer.
This year's gala brought a variety of emotions to the audience: from empathy with the unspoken struggles of infertility during the stage interaction with families longing for children, to the joy of finally holding their beloved children after much anticipation, showcased through the artistic program "Tears of Happiness" directed by Meritorious Artist Tu Long and performed by artists from the Military Cheo Theater.

In addition to the selected families for free IVF this year, nearly 30 military families, along with their children born from the first phase of the "Love Spreads" program, were present to inspire hope and trust among their peers, as well as express gratitude to the organizers and the medical staff who made their dreams of parenthood a reality.
The Gala "Seeds of Aspiration" this year was not just an artistic program or a simple ceremony for announcing and granting support, but also a reunion and return home—a place where the happiness of military families flourishes.
It is evident that the stories of military families receiving 100% support for IVF in 2021, 2022, and 2023 serve as a source of motivation for many other couples struggling with infertility on their journey to find their beloved children. The starting point may be incredibly challenging, seemingly leading to a point of giving up, but with love, community support, and perseverance, miracles will eventually come to these families.

GENTIS, wishing to spread the message "giving is everlasting," continues to accompany this year’s program as a sponsor, to provide additional trust and strength to military families. GENTIS hopes that this partnership will help military families remain steadfast on their arduous journey to parenthood. The starting point may be difficult, but with faith, love, and perseverance, miracles will eventually arrive for military families.
Through the Gala "Seeds of Aspiration," GENTIS aims to contribute even more to charitable efforts in the community, spreading the message "giving is everlasting" to collectively build a sustainable society and enhance the physical and intellectual well-being of the Vietnamese people.
            [content_more] => 
            [meta_title] => GENTIS Accompanies the Journey of Spreading Love at the Gala "Seeds of Aspiration"
            [meta_description] => On the evening of December 7, 2024, the second Gala "Seeds of Aspiration" was successfully held at the Military Broadcasting and Television Center. During the event, the organizers announced and awarded the decision to support 100% of the costs for In Vit
            [meta_keyword] => GENTIS
            [thumbnail_alt] => 
            [post_id] => 1272
            [category_id] => 4
        )

    [4] => stdClass Object
        (
            [id] => 1271
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => mti09930.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 1
            [displayed_time] => 2024-12-30
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2024-12-30 16:32:34
            [updated_time] => 2025-01-02 08:56:29
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 0
            [language_code] => en
            [slug] => Genetic-counseling-and-pgt-testing-from-international-guidelines-to-clinical-practice-in-vietnam
            [title] => Genetic Counseling and PGT Testing: From International Guidelines to Clinical Practice in Vietnam
            [description] => Currently, the demand for Preimplantation Genetic Testing (PGT) among couples at high genetic risk, who wish to have healthy children, is increasing. Preimplantation Genetic Testing (PGT) was developed to screen and detect genetic abnormalities in embryos before they are implanted into the mother’s uterus.
            [content] => 
With advances in technology and testing methods, PGT continues to be developed and clinically validated, thereby improving the success rates of assisted reproductive treatments. This is especially beneficial for parents with genetic diseases, allowing them to have healthy children free from genetic disorders.
According to global publications and studies, using next-generation sequencing (NGS) technology, current PGT tests can screen for and detect abnormalities in chromosome number (aneuploidy) across 23 pairs of chromosomes, known as PGT-A, structural chromosome abnormalities (addition/deletion/duplication), known as PGT-SR, single-gene disorders, known as PGT-M, and recently, some reports have emerged regarding the development of PGT for polygenic diseases (PGT-P). As the use and complexity of preimplantation genetic testing (PGT) increases, genetic counseling has become an essential part of modern medicine. GENTIS successfully organized a scientific seminar on "Genetic Counseling and PGT Testing: From International Guidelines to Clinical Practice in Vietnam."

At the seminar, Specialist Doctor Level 1 Nguyen Van Thong,, Head of the Department of Medical Genetics at Hung Vuong Hospital, explained: "Genetic counseling is a process that provides information, support, and guidance related to genetics and genetic risk factors for individuals or families. It helps assess the likelihood of inheriting genetic diseases based on family history or genetic test results. Additionally, it provides knowledge about genetic-related diseases or conditions, such as cancer, genetic disorders, or congenital abnormalities.
Furthermore, doctors will counsel on the benefits, limitations, and risks of genetic tests to help patients make informed decisions. Once the genetic test results are available, the doctor will explain the results and their implications for personal and family health. In addition, genetic counseling also provides psychological support to help patients and families deal with worries or emotions related to the results or genetic risks. Moreover, doctors will discuss follow-up, treatment, or prevention measures based on genetic risks."

Specialist Doctor Level 1 Nguyen Van Thong, also emphasized the importance of collaboration among genetic specialists, infertility doctors, embryologists, and healthcare workers to ensure the highest efficacy in the testing process. He also shared the role of PGT in supporting couples to have healthy children by screening and detecting genetic abnormalities. Technological advancements in PGT-A/SR and PGT-M not only increase the chances of successful pregnancies but also reduce the risks of miscarriage and serious genetic diseases in the fetus.
From a clinical perspective, Dr. Le Thi Minh Chau, Head of the Infertility Department at Tu Du Hospital, shared that over the past thirty years, there have been rapid advancements in genetic testing and assisted reproductive technology, reshaping the PGT testing process. The development of whole genome amplification (WGA) tools, combined with optimized hormonal stimulation protocols and more effective cryopreservation methods, has led to more accurate diagnoses and improved clinical outcomes. Furthermore, the shift from day 3 to day 5 or early day 6 embryo biopsy has altered the timeline for a typical PGT clinical process.

Although PGT helps reduce pregnancy terminations, in cases such as families with single-gene disorders, PGT is a relevant option for preimplantation genetic diagnosis. However, PGT remains a solution that requires discussion and consensus guidelines. Some of the complexities in the IVF process are especially relevant for couples without fertility issues, including the risk of diagnostic errors, potential embryo damage from invasive procedures, and ethical concerns. Therefore, the decision to undergo PGT is complex and always involves a stressful decision-making process.
Sharing her experience with PGT testing in Europe, Prof. Dr. Francesca Spinella, Senior Medical Information Specialist at Eurofins Genoma Group and Senior Consultant at GENTIS, explained: "Preimplantation Genetic Testing is a growing trend in Europe and globally. PGT analyzes genetic abnormalities (gene level and chromosomal abnormalities) in embryos before transferring them into the mother's uterus, helping to select embryos with a high implantation potential and a good chance of producing a healthy baby. However, in Europe, only reputable tests such as PGT-A, PGT-SR, and PGT-M are accepted and widely monitored by the ESHRE PGT Consortium."
The ESHRE PGT Consortium, founded in 1997, is responsible for collecting data on the accuracy, reliability, efficacy, and safety of PGT-A, PGT-M, and PGT-SR. It also establishes minimum standards and promotes best practice guidelines. Additionally, the Consortium facilitates the exchange of ideas and perspectives among members.
At the seminar, Prof. Dr. Francesca Spinella also introduced new PGT tests being developed at Eurofins Genoma Group. She noted that Eurofins Genoma Group is researching and developing a new PGT testing package called PGT Next. PGT Next, in addition to detecting chromosomal abnormalities such as PGT-A/SR, can also detect aneuploidy, identify euploid embryos without abnormalities, even in cases of embryo morphological abnormalities.
Through the seminar "Genetic Counseling and PGT Testing: From International Guidelines to Clinical Practice in Vietnam," GENTIS hopes that attendees have gained new information and knowledge about preimplantation genetic testing (PGT) and a clearer understanding of the value and applicability of PGT tests in assisted reproduction. This will contribute to improving clinical outcomes, supporting patients in making informed decisions, and increasing the chances of successful pregnancies and healthy babies.
            [content_more] => 
            [meta_title] => Genetic Counseling and PGT Testing: From International Guidelines to Clinical Practice in Vietnam
            [meta_description] => Currently, the demand for Preimplantation Genetic Testing (PGT) among couples at high genetic risk, who wish to have healthy children, is increasing
            [meta_keyword] => GENTIS,pgt
            [thumbnail_alt] => 
            [post_id] => 1271
            [category_id] => 4
        )

    [5] => stdClass Object
        (
            [id] => 1270
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => mti09930.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 1
            [displayed_time] => 2024-12-28
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2024-12-28 11:03:28
            [updated_time] => 2024-12-28 11:07:38
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 0
            [language_code] => en
            [slug] => Gentis-successfully-organized-the-PGT-genetic-testing-counseling-from-international-guidelines-to-clinical-practice-in-vietnam-scientific-symposium
            [title] => GENTIS successfully organized the “PGT genetic testing counseling: From international guidelines to clinical practice in Vietnam” scientific symposium.
            [description] => With the aims to help doctors and experts in the assisted reproductive field update latest knowledge and information on the applications of PGT, GENTIS had held the science symposium with the theme “PGT genetic testing counseling: From international guidelines to clinical practice in Vietnam” at Equatorial Hotel, 242 Tran Binh Trong Street, Ward 4, District 5, Ho Chi Minh City.

            [content] => 
The event, which took place on Dec.14 gathered heaps of prestigious experts in the field of reproductive assistance, both domestically and internationally. Notably, The conference had the presence of 3 chairpersons: Dr. Le Quang Thanh - Former Director of Tu Du Hospital; Assoc Prof. Dr. Hoang Thi Diem Tuyet - Director of Hung Vuong Hospital; and Dr. Pham Dinh Minh - Director of R&D Department at GENTIS.
The conference was honored to have the companions of 3 leading reporteres in the assisted reproductive field in Vietnam as well as Italy. The in-depth reports  provided comprehensive perspectives towards advancements in PGT testing

Specialist Doctor Level 1 Nguyen Van Thong, Head of the Department of Medical Genetics at Hung Vuong Hospital, shared on: “Genetic Counseling Before and After PGT Testing: Practical Experience”. Dr. Thong explained  that genetic counseling is the process of providing information, support, and guidance regarding genetics and genetic risk factors for individuals or families. This helps assess the risk of genetic diseases based on family history or genetic test results. It also involves educating patients about genetic-related conditions such as cancer, genetic disorders, or congenital abnormalities.
In addition, the counselor discusses the benefits, limitations, and risks of genetic testing to help patients make informed decisions. After receiving genetic test results, doctors explain the findings and their implications for the individual's and family's health. Furthermore, genetic counseling also provides psychological support to help patients and families cope with the concerns or emotions related to the results or genetic risks. Additionally, doctors will work with patients to discuss monitoring, treatment, or preventive measures based on genetic risks.

The presentation also highlighted the importance of collaboration between genetic experts, infertility specialists, embryologists, and healthcare professionals to ensure maximum effectiveness in the testing process. Dr. Thong further shared the role of PGT testing in helping couples have healthy children through the screening and detection of genetic abnormalities. Technological advancements in PGT-A/SR, PGT-M, and PGT-Max 1 not only increase the chances of successful pregnancy but also minimize the risks of miscarriage and severe genetic diseases in the fetus.
Assoc. Prof. Dr. Francesca Spinella, Senior Medical Information Specialist at Eurofins Genoma Group and Senior Expert Advisor at GENTIS, presented on "Advancements in PGT and Genetic Counseling." Dr. Spinella shared the latest data and trends from the ESHRE PGT Consortium, providing an in-depth view of the current status of PGT and genetic counseling for PGT testing in Europe.

Additionally, she shared experiences from the Eurofins Genoma lab with PGT-Next, an advanced technology combining genetic evaluation and DNA analysis, opening up new potential for improving clinical outcomes. She presented initial results and the potential of this test for future IVF applications.
Dr. Le Thi Minh Chau, Head of the Infertility Department at Tu Du Hospital, presented on "Screening for Genetic Abnormalities in PGT from a Clinical Perspective." In this presentation, Dr. Chau shared practical experience from clinical cases of PGT testing at Tu Du Hospital.

Dr. Chau noted that over the past thirty years, there have been rapid technological advancements in genetic testing and assisted reproduction, reshaping the PGT process. The development of whole genome amplification (WGA) tools, along with the implementation of optimized hormonal stimulation protocols and more effective cryopreservation methods, has led to more accurate diagnoses and improved clinical outcomes. Furthermore, the shift from day 3 to day 5 or early day 6 embryo biopsy has changed the timing of a typical PGT clinical process.
Although PGT helps reduce the need for pregnancy termination in certain cases, such as in families with single-gene disorders, PGT remains the only relevant choice for prenatal diagnosis. However, PGT is a solution that requires careful discussion and consensus guidelines. Among the challenges are the complexity of the IVF procedure, especially for couples with no fertility issues, the risk of misdiagnosis, potential embryo damage from invasive procedures, and some ethical concerns. Therefore, the decision to undergo PGT is complex and always involves a stressful decision-making process.
Through these three in-depth presentations and lively discussions among the chairpersons, speakers, and conference participants, GENTIS hopes that attendees gained valuable insights and the latest knowledge about Preimplantation Genetic Testing (PGT). Furthermore, it helped participants understand the value and practical applications of PGT tests in reproductive medicine, contributing to improving clinical outcomes and supporting patients in making informed decisions.

            [content_more] => 
            [meta_title] => GENTIS successfully organized the “PGT genetic testing counseling: From international guidelines to 
            [meta_description] => GENTIS had held the science symposium with the theme “PGT genetic testing counseling: From international guidelines to clinical practice in Vietnam” at Equatorial Hotel, 242 Tran Binh Trong Street, Ward 4, District 5, Ho Chi Minh City.

            [meta_keyword] => GENTIS,PGT
            [thumbnail_alt] => 
            [post_id] => 1270
            [category_id] => 4
        )

    [6] => stdClass Object
        (
            [id] => 1267
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => bf8c944f16e1acbff5f0.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2024-12-16
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2024-12-18 10:18:13
            [updated_time] => 2024-12-28 11:21:19
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Associate-Professor-Francesca-Spinella-visits-Gentis-partner-hospitals-strengthening-collaboration-and-advancing-genetic-testing-in-vietnam
            [title] => Associate Professor Francesca Spinella Visits GENTIS Partner Hospitals: Strengthening Collaboration and Advancing Genetic Testing in Vietnam
            [description] => During her visit to Vietnam, Professor Francesca Spinella (Senior Medical Information Specialist at Eurofins Genoma Group and Senior Expert Advisor to GENTIS) engaged in a series of significant activities at GENTIS and with partner institutions, including Hanoi’s Infertility and Andrology Hospital, Hanoi General Hospital, and Lac Viet Friendship Hospital. These expert meetings concluded successfully, laying the foundation for deeper, future collaboration between GENTIS, Genoma, and the partner hospitals.
            [content] => 
Professor Francesca Spinella's Official Visit to GENTIS Partner Institutions
As part of her work trip to Vietnam, Professor Francesca Spinella, accompanied by GENTIS experts, visited several prominent institutions in the field of reproductive health, including Lac Viet Friendship Hospital, Hanoi General Hospital, and Hanoi Infertility and Andrology Hospital. These hospitals are strategic partners of GENTIS in implementing and applying advanced genetic testing techniques.
The first stop for Professor Francesca Spinella and the GENTIS team was Lac Viet Friendship Hospital. Professor Ivan Reich, Director of the Vietnam IVF Center, along with the medical and lab teams, welcomed the group and held productive discussions with Professor Spinella and the GENTIS experts.
At this hospital, Professor Spinella gave a brief presentation on “Latest Updates in Genetic Testing for Reproductive Support, Sharing Experience from Europe.” She highlighted the advanced PGT (Preimplantation Genetic Testing) techniques used at Eurofins Genoma Group, offering valuable insights to doctors and enhancing their knowledge of the latest technologies. This, in turn, helps improve the quality of diagnosis and treatment for couples seeking to have children.

At Hanoi General Hospital, Professor Spinella continued to share knowledge on modern genetic methods used globally, discussing how to implement these practices in treatment. Of particular note were the latest PGT techniques for screening genetic abnormalities before in vitro fertilization (IVF). This is crucial as demand for reproductive healthcare rises, with more couples aiming for healthy children, especially those dealing with genetic conditions. The session was well-received by the leadership and medical staff at the Hanoi IVF Center.
The final visit for the GENTIS delegation was to Hanoi Infertility and Andrology Hospital. There, Professor Spinella and the GENTIS team conducted a direct expert exchange on pre-implantation genetic testing (PGT) packages and addressed numerous questions from the medical staff. The meeting provided fresh perspectives to doctors, helping them enhance their expertise in patient counseling and treatment.
After these visits, Professor Francesca Spinella expressed her admiration and positive impressions of the professional standards, systematic investment, and the noble mission of the hospitals in Vietnam. She also extended her gratitude to the representatives of the institutions for their warm and thoughtful reception.
The Importance of Collaboration between GENTIS and Vietnamese Hospitals
Professor Spinella’s visit to Vietnam provided an excellent opportunity for GENTIS and partner hospital doctors and experts to access advanced knowledge in reproductive support, and opened the door to long-term collaboration. With the mission of "Enhancing the physical and intellectual well-being of the Vietnamese people," GENTIS is committed to supporting partner hospitals in Vietnam by boosting professional capabilities, improving treatment quality, and increasing success rates in infertility treatment. With the backing of top experts, GENTIS pledges to stand by Vietnamese hospitals and families as they pursue their dreams of parenthood.
            [content_more] => 
            [meta_title] => Associate Professor Francesca Spinella Visits GENTIS Partner Hospitals: Strengthening Collaboration 
            [meta_description] => During her visit to Vietnam, Professor Francesca Spinella (Senior Medical Information Specialist at Eurofins Genoma Group and Senior Expert Advisor to GENTIS) engaged in a series of significant activities at GENTIS and with partner institutions
            [meta_keyword] => gentis,pgt
            [thumbnail_alt] => 
            [post_id] => 1267
            [category_id] => 4
        )

    [7] => stdClass Object
        (
            [id] => 1266
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => 85b7bab01dd2a08cf9c3.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2024-12-17
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2024-12-18 08:59:53
            [updated_time] => 2024-12-18 09:02:10
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => https://gentis.com.vn/tin-tuc-c4/gentis-duoc-cuc-thue-thanh-pho-ha-noi-tuyen-duong-doanh-nghiep-nop-thue-tieu-bieu-thu-do-nam-2023-d1266
            [title] => GENTIS was honored by the Hanoi Tax Department as an outstanding tax-paying enterprise in the capital in 2023
            [description] => On the morning of December 17, Genetic Testing Service Joint Stock Company (GENTIS) was honored by the Hanoi Tax Department as an outstanding tax-paying enterprise in the capital in 2023.
            [content] => 
The conference "Commending Typical Taxpayers of the Capital in 2023" was solemnly held by the Hanoi Tax Department to honor organizations and individuals in Hanoi who have made efforts to overcome many challenges, maintain and stabilize effective production and business along with good implementation of tax policies and laws, contributing to the completion of the State budget revenue estimate while promoting the emulation movement in the capital.

GENTIS has passed the strict assessment criteria for good compliance with tax laws, efforts to overcome difficulties and made great contributions to the State budget.
With good implementation of tax policies and laws, at the Conference "Commending Typical Taxpayers of the Capital in 2023", GENTIS was honored to receive a Certificate of Merit from the Director of the Hanoi Tax Department. Established in 2010, GENTIS always respects and upholds the principles of the rule of law and sustainable development. Operating based on 5 core values: prestige, creativity, dedication, respect, continuous learning, GENTIS has increasingly improved its position in the field of genetic analysis, bringing many job opportunities for employees, contributing to the innovation and development of the country's economy.
The Certificate of Merit for Outstanding Taxpayers of the Capital is a testament to GENTIS's business efforts and a recognition of the Company's positive contributions to the construction and development of the economy and society.

This special award from the Hanoi Tax Department is a great honor and encouragement for the Board of Directors, officers and employees of GENTIS Company in working together to overcome the difficult challenges, continue to fulfill tax obligations and become a model citizen enterprise of the capital Hanoi.
            [content_more] => 
            [meta_title] => GENTIS was honored by the Hanoi Tax Department as an outstanding tax-paying enterprise in the capita
            [meta_description] => On the morning of December 17, GENTIS was honored by the Hanoi Tax Department as an outstanding tax-paying enterprise in the capital in 2023.
            [meta_keyword] => 
            [thumbnail_alt] => 
            [post_id] => 1266
            [category_id] => 4
        )

)